Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly: Aspirin in Reducing Events in the Elderly (ASPREE)

By Nelson M.R.   Reid C.M.  

Drugs & Aging, Vol. 20, Iss. 12, 2003-01 ,pp. : 897-903

Adis International

Access to resources Recommend Favorite

Aspirin Use for the Primary Prevention of Cardiovascular Disease in the Elderly

By Sarbacker G. Blair   Lusk Kathleen A.   Flieller Lauren A.   Van Liew Jeffrey R.  

The Consultant Pharmacist, Vol. 31, Iss. 1, 2016-01 ,pp. : 24-32

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Low-Dose Aspirin Therapy for Cardiovascular Prevention: Quantification and Consequences of Poor Compliance or Discontinuation

By Herlitz Johan  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 125-141

Adis International

Access to resources Recommend Favorite

Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis

By Younis Naveed   Williams Steven   Ammori Basil   Soran Handrean  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1459-1466

Informa Healthcare

Access to resources Recommend Favorite

A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction

By Lamotte Mark  

PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. : 783-795

Adis International

Access to resources Recommend Favorite